J Clin Microbiol 1998, 36:1271–1276 PubMed 142 Rhead JL, Letley

J Clin Microbiol 1998, 36:1271–1276.PubMed 142. Rhead JL, Selleckchem ABT 263 Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC: A new Helicobacter pylori vacuolating cytotoxin determinant, JPH203 mw the intermediate region, is associated with gastric cancer. Gastroenterology 2007, 133:926–936.PubMedCrossRef 143. McClain MS, Shaffer CL, Israel DA, Peek RM Jr, Cover TL: Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics 2009, 10:3.PubMedCrossRef 144. Xie W, Zhou C, Huang RH: Structure of tRNA dimethylallyltransferase: RNA modification through a channel. J Mol

Biol 2007, 367:872–881.PubMedCrossRef 145. Blokesch M, Albracht SP, Matzanke BF, Drapal NM, Jacobi A, Bock A: The complex between hydrogenase-maturation proteins HypC and HypD is an intermediate in the supply of cyanide to the active site iron of [NiFe]-hydrogenases. J Mol Biol 2004, 344:155–167.PubMedCrossRef 146. Blokesch M, Bock A: Properties

selleck kinase inhibitor of the [NiFe]-hydrogenase maturation protein HypD. FEBS Lett 2006, 580:4065–4068.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions MK and YF contributed to informatics analysis and wrote the manuscript. YF carried out experimental verification of sequences of molybdenum-related genes and acetate unless pathway related genes. KY, TT, and IU contributed to informatics analysis. NH and NT

contributed to genome DNA preparation. KO and MH contributed to sequencing and assembly. MY and TA provided the strains. I.K. contributed to design, analysis and writing. All the authors discussed the results and commented on the manuscript. All the authors read and approved the final manuscript.”
“Background Candida albicans is both a commensal and a pathogenic yeast, which is responsible for severe infections in humans, particularly in immunocompromised persons, such as AIDS and cancer patients, diabetics, newborns and the elderly [1, 2]. Although several anti-Candida agents are currently available, such as amphotericin B, azoles and echinocandins, there is clearly a need for new specific anti-fungal agents and drug-targets [3]. The cell wall of C. albicans is an essential organelle that helps to withstand osmotic pressure and determines the shape of the cell. The cell wall is a plastic and dynamic structure, whose macromolecular composition, molecular organization and thickness can greatly vary depending on environmental conditions. The cell wall construction is also tightly controlled in space and time by many genes [4]. Within a host-parasite relationship, the cell wall of C. albicans lies at the crossroads of pathogenicity and therapeutics.

Comments are closed.